It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
This is indeed one controversial subject. What is potentially behind all of this is that we don't have physicians linked in here. When you stop and give this some thought, who do you want discussing your healthcare with you, your family practice doctor most of us would probably say,...
Genetic testing gave this man an option of having a defibrillator based on family history, and wrote a book about it. After having seen his father drop dead and other genetic findings, he determined he should have the device. It has not been an easy road and he wrote a book about his experience...
This gives a whole new meaning to the old redneck slang term of “swapping spit”. One more way to market oneself through genetics and single life. One question comes to mind, can they do this in California and New York? Even though the web site states this is specifically for dating...
Yesterday I posted about Bank of American hiring more research analysts in the area of healthcare investing and and also stated that Blogs are now becoming part of the research process , I have found several who read this blog. This page relates back to a a post about the commitment of the DeCode...
Recently I had posted about 2 other programs and here probably the oldest program is in place from Stanford University. Basically, all you need to do is download and install the screensaver and let it go to work when you are not using your computer. By donating your time and processors...
When will it start paying the bills? The science and development is somewhat fragmented like the rest of health care, and this is not to say in any way that phenomenal breakthroughs are not occurring by any means as they are. Part of the problem is having enough data, real time data for one...
A couple weeks ago I had a couple posts referencing the partner ship with Anthem Blue Cross with utilizing their data bases for such a project as well...The new FDA white paper, titled "The Sentinel Initiative -- A National Strategy for Monitoring Medical Product Safety," ... totally amazing...
This is a good thing, and let's hope it has more teeth than HIPAA...and down the road as the legal process continues to grow...what exactly will constitute a genetic test...that needs to be outlines clearly so later a test that an individual thought was a GINA related test is not construed or determined...